Author: admin

Fruit and vegetable juices can have harmful interactions with drugs and supplements. Juice may not mix well with statins, antibiotics, diuretics, warfarin, allergy meds or iron.  If you regularly drink juice, be sure to tell your health care provider and pharmacist. If you take supplements or medications in the morning, you may be reaching for a glass of your favorite juice to make taking them a bit easier. This might seem like a good move (we all need our vitamin C, after all!). But this practice can result in interactions that can negatively impact the effectiveness of your medications or supplements. Or…

The latest ETH micro robot is this small. [Luca Donati / lad.studio Zurich] Researchers headed by a team at ETH Zurich have developed a magnetically guided microrobotics system that they say can navigate the body’s intricate passageways and vasculature to deliver drugs with pinpoint accuracy. Headed by Fabian Landers, PhD, a postdoctoral researcher at the Multi-Scale Robotics Lab at ETH Zurich, the team’s modular, magnetically guided microrobotic platform integrates an electromagnetic navigation system (Navion) with a custom release catheter and drug-loaded, dissolvable capsule. The investigators tested the platform in vitro using human vasculature models and in vivo in sheep and pigs under realistic clinical…

Evosep, a global leader in proteomics solutions, is proud to announce a new initiative at HUPO 2025 aimed at solving one of LCMS based proteomics most persistent challenges: sample preparation. Building on its legacy of standardizing proteomics LC separation, Evosep is now expanding upstream to deliver robust, and reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics. What to Expect Evotip based Standardized Kits: Designed for reproducibility and minimal manual handling. Reference Protocols: Harmonized methods for consistent results across labs. Evosep Sample Preparation System: Designed for efficient and robust standardized sample handling and processing. Transparent…

T Truong, researcher1, M Ahmed, researcher1, K Gamayata, consultant2, T Arachi, consultant3 1University of Oxford, Oxford, UK2Manchester Metropolitan University, Manchester, UK3Oxford University Hospitals NHS Foundation Trust, Oxford, UKCorrespondence to: T Truong tiffany.truong{at}seh.ox.ac.ukPolicies for research and practice must acknowledge how sex affects outcomesMore than 109 million women globally are living with heart and circulatory disease,1 yet they are more likely than men to be underdiagnosed, undertreated, and under-represented in research trials.2 This persistent gender gap is more than a clinical shortcoming; it is a deeper structural failure in health policy. Women are projected to continue to have more disability adjusted life…

Credit: 7activestudio/ Getty Images With almost 20 already approved since 2000, including some blockbusters, antibody drug conjugates (ADCs) are clearly one of the biggest waves in cancer research. But even the older, less complicated, targeted therapies, including pioneer Herceptin that targets HER2, have had their challenges in the testing lab. Pathologists hunched over microscope slides sometimes had difficulty coming to the same conclusions. Now, experts are betting that AI-driven digital pathology can make the ADC revolution go more smoothly. “We are at the tip of the iceberg with ADCs, and digital pathology opens new frontiers,” Jeff Allen, PhD, president and CEO…

In addition to treating diabetes and obesity, GLP-1 drugs like Ozempic and Wegovy also appear to help with a range of other serious illnesses, from heart disease to addiction.A new study suggests these medications may offer some protective benefits for people with colon cancer, particularly those with obesity.In a new study, people with colon cancer who took GLP-1s were slightly less than half as likely as people with colon cancer who didn’t take the medications to die within five years.“The main message is that improving metabolic health may do more than lower blood sugar or help with weight loss —…

A new autopsy just confirmed the first U.S. death from tick-borne alpha-gal syndrome.Alpha-gal syndrome causes delayed allergic reactions to mammal meat, dairy and some medicines after tick bites.Symptoms can lessen with strict diet changes; experts urge testing for those with unexplained post-meat illness. This week, the cause of a 47-year-old airline pilot’s death, which was once a mystery, was revealed. The autopsy results were published in The Journal of Allergy and Clinical Immunology, and they indicated that the New Jersey man had died from alpha-gal syndrome, a meat allergy developed by a tick bite. This is the first reported death…

Download the Nature Podcast Extra 14 November 2025Yoshua Bengio, considered by many to be one of the godfathers of AI, has long been at the forefront of machine-learning research . However, his opinions on the technology have shifted in recent years — he joins us to talk about ways to address the risks posed by AI, and his efforts to develop an AI with safety built in from the start. Nature: ‘It keeps me awake at night’: machine-learning pioneer on AI’s threat to humanitySubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your…

One of the most important factors to consider before buying a new pair of walking or running shoes is their level of arch support. It’s a feature podiatrists constantly talk about, as “proper arch support is important for providing stability and alignment, which will help support your body from the ground up,” said Dr. Janine Ferrigno-Taddeo, DPM, podiatrist and vice president of Millburn Podiatry Group, PC, in a previous EatingWell article.  This is especially true if you have conditions such as plantar fasciitis, chronic foot pain or fat pad atrophy, although this list could go on. Oftentimes, however, shoes that…

Brittany Janis (right) and Cathy Richards.Credit: Benn Craig (Brittany Janis)In February, the administration of US President Donald Trump barred scientists who work at federal agencies from attending the latest plenary session of the Intergovernmental Panel on Climate Change (IPCC) in Hangzhou, China. The move ended US participation in what the White House described as “international agreements and initiatives that do not reflect our country’s values”. It marked a sharp break from decades of US leadership in the IPCC, where US scientists and diplomats have helped steer negotiations, shape reports and fund the process that underpins global climate action.Nature Index 2025…